Lisata Therapeutics, Inc.
LSTA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000320017
No open-market purchases or sales by Lisata Therapeutics, Inc. insiders were filed in the last 90 days; 31 institutions reported holding it in 13F filings for Q2 2026, worth $3.70M in total; no superinvestor holds it.
Q3 2022 vs. Q2 2022
How the institutions holding Lisata Therapeutics, Inc. changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Q3 2022 | Change |
|---|---|---|---|
| Holders | 36 | 22 | −14 |
| SharesConverted for a 1-for-15 split | 628.9K | 470.7K | −158.2K (−25.2%) |
| Value | $5.00M | $2.17M | −$2.83M (−56.5%) |
New holders (3)
Institutions that held Lisata Therapeutics, Inc. at the end of Q3 2022 but not at the end of Q2 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Dimensional Fund Advisors LP | 12,333 | $57.0K | 0.00% |
| Cook Wealth Management Group LLC | 12,175 | $51.0K | 0.06% |
| FMR LLC | 1 | $0 | 0.00% |
Sold out (17)
Institutions that held Lisata Therapeutics, Inc. at the end of Q2 2022 and filed for Q3 2022 without it.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| Ra Capital Management, L.P. | 752,500 | $399.0K |
| IPG Investment Advisors LLC | 137,552 | $73.0K |
| Northern Trust Corp | 85,855 | $46.0K |
| Two Sigma Advisers, LP | 68,800 | $36.0K |
| CIBC Private Wealth Group, LLC | 55,525 | $29.0K |
| Two Sigma Securities, LLC | 18,248 | $10.0K |
| Tower Research Capital LLC (TRC) | 18,244 | $10.0K |
| Jane Street Group, LLC | 17,156 | $9.00K |
| Summit Trail Advisors, LLC | 17,730 | $9.00K |
| Susquehanna International Group, LLP | 12,958 | $7.00K |
| Tarbox Family Office, Inc. | 11,542 | $6.00K |
| Creative Planning | 10,075 | $5.00K |
| Alterna Wealth Management, Inc | 10,000 | $5.00K |
| Spire Wealth Management | 1,087 | $1.00K |
| Kelly Financial Services LLC | 10 | $5 |
| Citigroup Inc | 2 | $0 |
| TSFG, LLC | 1 | $0 |